Covid-19: EU countries spent over €220m stockpiling remdesivir despite lack of effectiveness
The drug’s manufacturer was aware of the negative results of the Solidarity trial before the European Commission struck a procurement deal with it, finds an investigation. Read the full article here. On 7 October the European Commission struck a so called joint procurement framework deal with the drug manufacturer Gilead, after reports the day before …
